Enanta Pharmaceuticals (ENTA) Preferred Dividend Payments (2012 - 2013)
Enanta Pharmaceuticals (ENTA) posted Preferred Dividend Payments of -$5.1 million for Q3 2013, down 506.11% on a QoQ basis from $1.2 million in Q1 2013, and down 479.28% year-over-year from $1.3 million in Q3 2012.
Enanta Pharmaceuticals (ENTA) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
Enanta Pharmaceuticals' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at -$5.1 million for Q3 2013.
- Quarterly Preferred Dividend Payments fell 479.28% year-over-year to -$5.1 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $15.0 million (changed N/A YoY) and the FY2013 annual result came in at -$2.5 million, down 147.07% from the prior year.
- Preferred Dividend Payments was -$5.1 million for Q3 2013 at Enanta Pharmaceuticals, down from $1.2 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $28.2 million in Q1 2012 and bottomed at -$5.1 million in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | -5.05 Mn |
| Mar 31, 2013 | 1.24 Mn |
| Dec 31, 2012 | 18.81 Mn |
| Sep 30, 2012 | 1.33 Mn |
| Jun 30, 2012 | 1.33 Mn |
| Mar 31, 2012 | 28.15 Mn |